NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing cancer drugs work for more rare tumors?
Disease control Not yet recruitingThis study tests whether two approved drugs, dabrafenib and trametinib, can shrink or control rare cancers that have a specific genetic change called BRAF V600. About 30 adults and children with various rare cancers will receive the drug combination. The goal is to see if these d…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Could a vaccine keep early prostate cancer in check?
Disease control Not yet recruitingThis study tests a new vaccine (TriAdeno) plus an immune-boosting drug (N-803) in men with early-stage prostate cancer who are currently just monitoring their cancer. The goal is to see if this combination can stop tumors from growing and reduce the need for more aggressive treat…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC